Multiple Sclerosis – Cladribine tablets (Mavenclad)

23rd January 2018 by Louise Hudman

Multiple Sclerosis – Cladribine tablets (Mavenclad)

This is a new guideline from NICE on a new treatment for MS. Obviously we won’t be prescribing this, but I thought it worth mentioning as we may see patients starting to use it.

It is an oral medication, given as short courses (eg for 2 years, it is given for just a few days in each of a couple of months). This compares to other medications, which are either daily and continuous, or injections, or IV medications given in hospital.

It will be used as a second line treatment in relapsing-remitting MS, or in rapidly evolving severe relapsing-remitting MS.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I was introduced to the local locum chambers several months ago when I made a career move from partnership. I now combine salaried and locum roles. The chambers provides helpful support, leadership, advice and governance and reduces professional isolation. This combination of support reassures me and helps me provide safe and consistent care to patients within the community . There is a useful, innovative online portal - LocumDeck - which helps me access local work and which has efficient systems for reconciliation of finance including pensions. I would highly recommend joining a locum chambers for any GPs starting out in the locum world ."

Dr Adrian Richardson

Dr Adrian Richardson

See the full list of features within our NASGP membership plans

Membership